Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dallas J Smith

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
MMWR. Morbidity and Mortality Weekly Report|December 21, 2023
SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral AntiviralsDallas J Smith, Anastasia Lambrou, Pragna Patel
Drugs - Real World Outcomes|August 16, 2025
Real-World Ibrexafungerp Use Patterns Among Patients with Commercial Health Insurance, United States, 2021-2023Kaitlin Benedict, Dallas J Smith, Jeremy A W Gold
Open Forum Infectious Diseases|May 27, 2024
Epidemiology of Cryptococcosis Among Patients With Commercial Health Insurance and Patients With Medicaid, United States, 2016-2022Kaitlin Benedict, Dallas J Smith, Jeremy A W Gold
Mycoses|September 4, 2025
New Asthma Diagnosis Codes or Short-Acting β<sub>2</sub> Agonist Prescriptions After Histoplasmosis Among Patients With Commercial Health Insurance, United States, 2018-2023Ian Hennessee, Kaitlin Benedict, Dallas J Smith, et al.
Journal of Clinical Microbiology|November 28, 2023
<i>Trichophyton indotineae</i> and other terbinafine-resistant dermatophytes in North AmericaShawn R Lockhart, Dallas J Smith, Jeremy A W Gold
Plos Neglected Tropical Diseases|September 4, 2025
Chromoblastomycosis and phaeohyphomycotic abscess-associated hospitalizations, United States, 2016-2021Dallas J Smith, Kaitlin Benedict, Shawn R Lockhart, et al.
Journal of the American Pharmacists Association : Japha|November 15, 2022
Global engagement of pharmacists in test and treat initiatives: Bringing care from clinics to communitiesDallas J Smith, Lily McGill, David Carranza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2025
Impact of fluconazole on outcomes of patients with primary pulmonary coccidioidomycosis: a commercial health insurance claims-based, propensity score matched analysisKaitlin Benedict, Ian Hennessee, Dallas J Smith, et al.
American Family Physician|October 21, 2025
Diagnosis and Management of Tinea InfectionsAvrom S Caplan, Jeremy A W Gold, Dallas J Smith, et al.
Emerging Infectious Diseases|September 29, 2025
Increased Rates of Purpureocillium lilacinum Mold among Laboratory Culture Results, United StatesDallas J Smith, Luisa F López, Meghan Lyman, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
MMWR. Morbidity and Mortality Weekly Report|December 21, 2023
SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral AntiviralsDallas J Smith, Anastasia Lambrou, Pragna Patel
Drugs - Real World Outcomes|August 16, 2025
Real-World Ibrexafungerp Use Patterns Among Patients with Commercial Health Insurance, United States, 2021-2023Kaitlin Benedict, Dallas J Smith, Jeremy A W Gold
Open Forum Infectious Diseases|May 27, 2024
Epidemiology of Cryptococcosis Among Patients With Commercial Health Insurance and Patients With Medicaid, United States, 2016-2022Kaitlin Benedict, Dallas J Smith, Jeremy A W Gold
Mycoses|September 4, 2025
New Asthma Diagnosis Codes or Short-Acting β<sub>2</sub> Agonist Prescriptions After Histoplasmosis Among Patients With Commercial Health Insurance, United States, 2018-2023Ian Hennessee, Kaitlin Benedict, Dallas J Smith, et al.
Journal of Clinical Microbiology|November 28, 2023
<i>Trichophyton indotineae</i> and other terbinafine-resistant dermatophytes in North AmericaShawn R Lockhart, Dallas J Smith, Jeremy A W Gold
Plos Neglected Tropical Diseases|September 4, 2025
Chromoblastomycosis and phaeohyphomycotic abscess-associated hospitalizations, United States, 2016-2021Dallas J Smith, Kaitlin Benedict, Shawn R Lockhart, et al.
Journal of the American Pharmacists Association : Japha|November 15, 2022
Global engagement of pharmacists in test and treat initiatives: Bringing care from clinics to communitiesDallas J Smith, Lily McGill, David Carranza, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2025
Impact of fluconazole on outcomes of patients with primary pulmonary coccidioidomycosis: a commercial health insurance claims-based, propensity score matched analysisKaitlin Benedict, Ian Hennessee, Dallas J Smith, et al.
American Family Physician|October 21, 2025
Diagnosis and Management of Tinea InfectionsAvrom S Caplan, Jeremy A W Gold, Dallas J Smith, et al.
Emerging Infectious Diseases|September 29, 2025
Increased Rates of Purpureocillium lilacinum Mold among Laboratory Culture Results, United StatesDallas J Smith, Luisa F López, Meghan Lyman, et al.
Pageof 7